The experiment reveals significant limitations that make clinical application premature and potentially dangerous. Severe complications emerged within 24 hours, progressive organ damage occurred despite heavy immunosuppression, and experts emphasize these lungs cannot independently sustain patients. Much more research is needed before considering human trials.